Albertini Andrea, an insider at Henry Schein Inc (HSIC), sold 65,900 shares of the company on December 9, 2025, at a price of $75.88 per share, totaling approximately $5.00 million. Following this transaction, Andrea retains 65,900 shares in the company.
Henry Schein, headquartered in Melville, New York, provides healthcare products and services to medical, dental, and veterinary practitioners. With a market cap of $9.0 billion, the company operates in segments including Global Distribution and Value-Added Services, Global Specialty Services, and Global Technology. The company employs about 25,000 people and reported a P/E ratio of 23.02 and an EPS of 3.17.
Insider selling can stem from various personal reasons such as diversification, tax planning, or other financial needs. While significant selling patterns may attract attention, they do not inherently signal negative sentiment about the company. Investors are encouraged to consider insider transactions alongside broader market trends and company fundamentals.
Insider trades are reported to the SEC, providing transparency into executive actions. However, a single transaction should be viewed as just one data point among many when evaluating a company's prospects. Patterns of activity across multiple insiders and time periods can offer more comprehensive insights.
Looking ahead, Henry Schein is scheduled to report earnings on May 4, 2026, with an EPS estimate of $1.29 and revenue expected to reach $3.4 billion. The subsequent earnings report is set for August 3, 2026, with an EPS estimate of $1.24 and revenue projections of $3.4 billion.